Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2019

Feb 16, 2019

30561_dirs_2019-02-15_ba2c68d4-3107-4fd4-8f11-bb844e5af179.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2019-02-14

Reporting Person: FELDBAUM CARL B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-14 Common Stock M 15000 $5.92 Acquired 30221 Direct
2019-02-14 Common Stock M 11500 $4.57 Acquired 41721 Direct
2019-02-14 Common Stock M 24000 $4.58 Acquired 65721 Direct
2019-02-14 Common Stock S 50500 $22.03 Disposed 15221 Direct
2019-02-15 Common Stock G 6700 Disposed 8521 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-14 Option (right to buy) $5.92 M 15000 Disposed 2020-05-18 Common Stock (15000.0) Direct
2019-02-14 Option (right to buy) $4.57 M 11500 Disposed 2019-05-23 Common Stock (11500.0) Direct
2019-02-14 Option (right to buy) $4.58 M 24000 Disposed 2020-05-22 Common Stock (24000.0) Direct

Footnotes

F1: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.01 to $22.08. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.

F2: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2010.

F3: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 24, 2012.

F4: The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013.